全文获取类型
收费全文 | 399226篇 |
免费 | 25966篇 |
国内免费 | 3058篇 |
专业分类
耳鼻咽喉 | 5617篇 |
儿科学 | 8478篇 |
妇产科学 | 10311篇 |
基础医学 | 56826篇 |
口腔科学 | 12275篇 |
临床医学 | 31753篇 |
内科学 | 82268篇 |
皮肤病学 | 9307篇 |
神经病学 | 28835篇 |
特种医学 | 15038篇 |
外国民族医学 | 82篇 |
外科学 | 63115篇 |
综合类 | 10076篇 |
现状与发展 | 2篇 |
一般理论 | 69篇 |
预防医学 | 18397篇 |
眼科学 | 9852篇 |
药学 | 32828篇 |
1篇 | |
中国医学 | 2456篇 |
肿瘤学 | 30664篇 |
出版年
2021年 | 3387篇 |
2019年 | 3258篇 |
2018年 | 5094篇 |
2017年 | 3891篇 |
2016年 | 4204篇 |
2015年 | 5047篇 |
2014年 | 6882篇 |
2013年 | 8693篇 |
2012年 | 12038篇 |
2011年 | 12117篇 |
2010年 | 7259篇 |
2009年 | 6794篇 |
2008年 | 10763篇 |
2007年 | 11499篇 |
2006年 | 11220篇 |
2005年 | 10178篇 |
2004年 | 9538篇 |
2003年 | 9175篇 |
2002年 | 8766篇 |
2001年 | 28524篇 |
2000年 | 28996篇 |
1999年 | 23861篇 |
1998年 | 5278篇 |
1997年 | 4339篇 |
1996年 | 3899篇 |
1995年 | 3548篇 |
1994年 | 3152篇 |
1993年 | 2875篇 |
1992年 | 16128篇 |
1991年 | 14919篇 |
1990年 | 14237篇 |
1989年 | 14047篇 |
1988年 | 12655篇 |
1987年 | 12140篇 |
1986年 | 11167篇 |
1985年 | 10394篇 |
1984年 | 6965篇 |
1983年 | 5646篇 |
1982年 | 2750篇 |
1979年 | 5519篇 |
1978年 | 3382篇 |
1977年 | 3006篇 |
1976年 | 2264篇 |
1975年 | 2659篇 |
1974年 | 3087篇 |
1973年 | 2889篇 |
1972年 | 2844篇 |
1971年 | 2788篇 |
1970年 | 2520篇 |
1969年 | 2554篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
T.-Y. Huang Y.-J. Hsia M.-Y. Sung Y.-T. Wu P.-C. Hsu 《International journal of oral and maxillofacial surgery》2021,50(8):1100-1106
Zygomatic implant treatment is widely applied for severe maxillary atrophy to help rehabilitate the maxillary dentition. This retrospective study was performed to evaluate the actual radiographic bone–implant contact (rBIC) lengths of zygomatic implants. The records of 28 patients who underwent zygomatic implant surgery and subsequent follow-up examinations between August 2013 and September 2018 in the Department of Oral and Maxillofacial Surgery, Taipei Tzu Chi Hospital were reviewed. The surgeries were performed by a single surgeon using the same treatment protocol. All patients had a computed tomography scan at 1 year after the surgery. Using three-dimensional imaging software, an investigator measured the rBIC lengths of 66 implants and documented their clinical status. The implant survival rate was 100%. The mean rBIC length was significantly longer in male patients than in female patients (20.80 ± 5.88 mm versus 17.79 ± 6.34 mm; P = 0.028). The mean rBIC length of double zygomatic implants was significantly longer when compared to that of single implants (21.11 ± 6.23 mm versus 17.75 ± 5.85 mm; P = 0.027). This article is novel in reporting the exact rBIC lengths of zygomatic implants in a clinical setting. The results showed that zygomatic implants are a viable treatment modality for full-mouth rehabilitation. 相似文献
32.
Alexander Real Chierika Ukogu Divya Krishnamoorthy Nicole Zubizarreta Samuel K. Cho Andrew C. Hecht James C. Iatridis 《The spine journal》2019,19(2):225-231
Background Context
Low back pain (LBP) is a common complaint in clinical practice of multifactorial origin. Although obesity has been thought to contribute to LBP primarily by altering the distribution of mechanical loads on the spine, the additional contribution of obesity-related conditions such as diabetes mellitus (DM) to LBP has not been thoroughly examined.Purpose
To determine if there is a relationship between DM and LBP that is independent of body mass index (BMI) in a large cohort of adult survey participants.Study Design
Retrospective analysis of prospectively collected National Health and Nutrition Examination Survey (NHANES) data to characterize associations between LBP, DM, and BMI in adults subdivided into 6 subpopulations: normal weight (BMI 18.5–25), overweight (BMI 25–30), and obese (BMI >30) diabetics and nondiabetics. Diabetes was defined with glycohemoglobin A1c (HbA1c) ≥6.5%.Patient Sample
11,756 participants from NHANES cohort.Outcome Measures
Percentage of LBP reported.Methods
LBP reported in the 1999-2004 miscellaneous pain NHANES questionnaire was the dependent variable examined. Covariates included HbA1c, BMI, age, and family income ratio to poverty as continuous variables as well as race, gender, and smoking as binary variables. Individuals were further subdivided by weight class and diabetes status. Regression and graphical analyses were performed on the study population as a whole and also on subpopulations.Results
Increasing HbA1c did not increase the odds of reporting LBP in the full cohort. However, multivariate logistic regression of the 6 subpopulations revealed that the odds of LBP significantly increased with increasing HbA1c levels in normal weight diabetics. No other subpopulations reported significant relationships between LBP and HbA1c. LBP was also significantly associated with BMI for normal weight diabetics and also for obese subjects regardless of their DM status.Conclusions
LBP is significantly related to DM status, but this relationship is complex and may interact with BMI. These results support the concept that LBP may be improved in normal weight diabetic subjects with improved glycemic control and weight loss, and that all obese LBP subjects may benefit from improved weight loss alone. 相似文献33.
34.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献
35.
Prevention Science - This study aimed to evaluate the effectiveness of the drug and violence resistance educational program (PROERD) on short-term secondary outcomes, such as intentions to use... 相似文献
36.
37.
38.
39.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis 下载免费PDF全文
40.